Tumor-derived lymphangiogenic growth factors (especially Vascular Endothelial Growth Factor-C (VEGFC)) can drive the formation of lymphatic vessels, providing an interface for lymphatic vessel invasion and distant metastasis [36]. The gene discussed is VEGFC; the disease is neoplasm.